This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Medlab Clinical 미래 성장
Future 기준 확인 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Medlab Clinical.
주요 정보
-44.7%
수익 성장률
-44.7%
EPS 성장률
Biotechs 수익 성장 | 15.2% |
매출 성장률 | 41.7% |
향후 자기자본 수익률 | n/a |
애널리스트 커버리지 | Low |
마지막 업데이트 | 04 May 2023 |
최근 미래 성장 업데이트
Recent updates
Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now
Oct 06Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?
Oct 05What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay
Feb 21Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years
Dec 30Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future
Nov 22수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
6/30/2024 | 4 | -22 | N/A | N/A | 1 |
6/30/2023 | 7 | -14 | N/A | N/A | 1 |
6/30/2022 | 2 | -8 | -9 | -9 | N/A |
3/31/2022 | 1 | -9 | -10 | -10 | N/A |
12/31/2021 | 4 | -12 | -11 | -11 | N/A |
9/30/2021 | 4 | -12 | -11 | -11 | N/A |
6/30/2021 | 1 | -10 | -10 | -10 | N/A |
3/31/2021 | 1 | -10 | -9 | -9 | N/A |
12/31/2020 | 1 | -11 | -8 | -8 | N/A |
9/30/2020 | 2 | -12 | -10 | -9 | N/A |
6/30/2020 | 3 | -13 | -11 | -10 | N/A |
3/31/2020 | 4 | -12 | -11 | -11 | N/A |
12/31/2019 | 4 | -12 | -12 | -12 | N/A |
9/30/2019 | 5 | -10 | -11 | -11 | N/A |
6/30/2019 | 5 | -8 | -11 | -10 | N/A |
3/31/2019 | 5 | -7 | -9 | -9 | N/A |
12/31/2018 | 5 | -6 | -7 | -7 | N/A |
9/30/2018 | 4 | -5 | -6 | -6 | N/A |
6/30/2018 | 4 | -5 | -5 | -5 | N/A |
3/31/2018 | 4 | -4 | -5 | -5 | N/A |
12/31/2017 | 5 | -4 | -5 | -5 | N/A |
9/30/2017 | 5 | -4 | -4 | -4 | N/A |
6/30/2017 | 4 | -4 | -4 | -4 | N/A |
3/31/2017 | 4 | -4 | -4 | -4 | N/A |
12/31/2016 | 4 | -4 | -4 | -4 | N/A |
9/30/2016 | 3 | -4 | -4 | -4 | N/A |
6/30/2016 | 3 | -3 | -4 | -4 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: MDC is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: MDC is forecast to remain unprofitable over the next 3 years.
고성장 수익: MDC is forecast to remain unprofitable over the next 3 years.
수익 대 시장: MDC's revenue (41.7% per year) is forecast to grow faster than the Australian market (4.8% per year).
고성장 수익: MDC's revenue (41.7% per year) is forecast to grow faster than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if MDC's Return on Equity is forecast to be high in 3 years time